Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

Clinical trial NCT05513664 · UNKNOWN

Trial details

NCT number: NCT05513664
Sponsor: Shanghai JMT-Bio Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Locally Advanced or Metastatic Non-Small Cell Lung Cancer EGFR Exon20 Insertion Mutations

Start date: 2022-09-01
Primary completion: 2023-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.